Showing results (1-10 of 427) with videos related to
Sort By:
Pageof 43
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2019
The Intersection between Tumor Angiogenesis and Immune SuppressionOsama E Rahma, F Stephen HodiCancer|September 5, 2020
Outcomes after resumption of immune checkpoint inhibitor therapy after high-grade immune-mediated hepatitisMichael Li, Jordan S Sack, Osama E Rahma, et al.Immunotherapy|June 13, 2022
Multiple high-grade and rare immune-related adverse events in a colon cancer patient with genomic and cytokine profilingKevin Tyan, Osama Abu-Shawer, Joanna Baginska, et al.Hepatology (Baltimore, Md.)|October 28, 2021
Effect of corticosteroid dosing on outcomes in high-grade immune checkpoint inhibitor hepatitisMichael Li, Danny Wong, Alexander S Vogel, et al.Asia-Pacific Journal of Clinical Oncology|May 21, 2010
Overcoming immunological tolerance to melanoma: Targeting CTLA-4F Stephen HodiClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Cytotoxic T-lymphocyte-associated antigen-4F Stephen HodiCancer Immunology, Immunotherapy : CII|January 22, 2021
Cytokine changes during immune-related adverse events and corticosteroid treatment in melanoma patients receiving immune checkpoint inhibitorsKevin Tyan, Joanna Baginska, Martha Brainard, et al.Gastroenterology & Hepatology|February 3, 2012
Therapeutic vaccines for gastrointestinal cancersOsama E Rahma, Samir N KhleifJournal of Gastrointestinal Oncology|June 2, 2015
Regression of hepatocellular carcinoma after treatment of hepatitis C: a case reportEmaculate Verla-Tebit, Osama E RahmaCancer Immunology Research|April 30, 2014
Anti-PD1 following ipilimumab for mucosal melanoma: durable tumor response associated with severe hypothyroidism and rhabdomyolysisLe Min, F Stephen HodiPageof 43